Esomeprazole and omeprazole could enhance the serum concentrations of benzodiazepines (through CYP2C19 inhibition) bringing about elevated adverse effects for example drowsiness, although the clinical relevance is reduced in most patients – monitor the affected individual for adverse effects (e.If affected individual are not able to resume their